Remicade 100 MG vials
Ended Awarded
- Contract number
- SPE2DB26FDV13
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,822
Award facts
- Contract value 100% obligated
- $15,822.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,822.35 delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. Remicade (infliximab) is a biologic immunosuppressant medication used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis, reflecting the critical pharmaceutical support required by military and federal healthcare systems. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. Through this prime contract vehicle, the company serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning itself as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FDV13?
SPE2DB26FDV13 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FDV13 worth?
The government has obligated $15,822 on SPE2DB26FDV13.
Is contract SPE2DB26FDV13 an order under another contract?
Yes. SPE2DB26FDV13 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDV13 competed?
The extent of competition for SPE2DB26FDV13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award